Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Идёт Россия Набор открыт

06111985_01

The First Prospective Randomized Study of the Removal of Large Benign Epithelial Neoplasms of the Colon by the EMR and ESD Method in Moscow, Russia.

Номер протокола06111985_01
ФазаФаза не указана
Участников по плану — во всех странах исследования110
Сроки10.12.2023 — 31.12.2026
Начало: 10 декабря 2023Окончание: 31 декабря 2026
Пройдено 96% планового срока

Постоянная ссылка: https://clinomir.ru/trials/nct/NCT07041229/

Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда

Простыми словами

Словарь терминов
  • Исследование идёт, в реестре указано, что набор участников открыт.
  • Возраст участников: 18–100 лет. Остальные условия — в блоке «Кто может участвовать».
  • По плану участвуют 110 чел. во всех странах исследования.
  • Плановое окончание — 12.2026.

Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.

Кто может участвовать

Возраст18–100 лет
ПолЛюбой
Здоровые добровольцынет
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 3 · невключение: 11

Критерии включения

  • Patient with benign non-invasive epithelial formations of the colon on a broad base (Is and II types), 20-60 mm in size
  • Age ≥ 18 years.
  • Signed informed voluntary consent for colonoscopy and removal of formations using the studied methods of EMR and ESD

Критерии невключения

  • . More than one large epithelial lesion on a broad base
  • Colon lesion less than 20 mm and more than 60 mm
  • Recurrent lesion.
  • Reasonable suspicion of an invasive lesion (cancer), including one with submucosal invasion based on the results of preoperative assessment (NICE - 3; JNET - 3; Kudo - Vn).
  • Presence of widespread malignant tumour in any part of the colon.
  • Use of other methods of endoscopic lesion removal.
  • IBD.
  • Infectious disease requiring systemic therapy
  • Patient on haemodialysis
  • Uncorrectable coagulopathy (INR> 1.5), inability to discontinue antithrombotic drugs.
  • Refusal to participate in the study. 12. General contraindications to endoscopic examination.

Источник: ClinicalTrials.gov, NCT07041229 · запись обновлена в реестре 27 июня 2025.

Дизайн и результаты

ДизайнРандомизированное, открытое (без ослепления), параллельные группы; цель — лечение
Участников по плану (все страны)110
Результатыбудут после окончания
Что измеряют — первичные конечные точки (5), вторичных — 1
  • Radicality of removal — 1 months after removal
  • Duration of the operation — at the time of the operation
  • Intraoperative complications — at the time of the operation
  • Postoperative complications — 1 months after removal
  • Relapse of education — 6 and 12 months after removal

Цель исследования

Benign epithelial neoplasms of the colon are a significant problem of colorectal surgery and health care not only because of their malignant potential, but also because of their prevalence among the working-age population. Adenomas are more often detected in men than in women (OR = 1.77; 95% CI = 1.66-1.89), increasing in men from 25% at 50-54 years to 39% in people over 70 years old and in women from 15% at 50-54 years to 26% at 70 years of age (p \< 0.001) \[1\]. Colonoscopy is the gold standard among all methods for diagnosing adenomas and adenocarcinomas of the colon. Endoscopic removal of colorectal polyps reduces the incidence and mortality from colorectal cancer (CRC) and is considered a necessary skill for all endoscopists performing colonoscopy \[2, 6\]. Endoscopic mucosal resection (EMR) was developed in 1984 by M. Tada et al. as a new technique for removing epithelial lesions of the gastrointestinal tract \[181\]. There are a number of aspects that cause additional complications during mucosectomy, such as convergence of folds, localization of large polyps between two folds, tumor spread beyond two folds, which are factors in tumor fragmentation and require additional study of their impact on long-term treatment outcomes. It is important to note that removal of colon tumors by fragmentation technique is associated with increased recurrence rate, however, in most cases these recurrent lesions are small in size and can be easily removed during dynamic colonoscopy. Predictably high recurrence rate during tumor fragmentation during removal indicates non-radical nature of the intervention performed and safety of this manipulation should be proven. Endoscopic submucosal dissection (ESD) is a relatively new method for removing superficial gastrointestinal neoplasms and was described at the end of the 20th century \[85\]. The development of the submucosal dissection technique was motivated by the difficulty of removing formations larger than 20 mm in a single block by endoscopic resection of the mucosa. Also, the association of tumor fragmentation during resection with a high risk of local recurrence and the difficulty of morphological evaluation of the removed specimen \[133, 136, 190\]. However, endoscopic submucosal dissection is a lengthy and energy-consuming procedure. According to Japanese authors, the average time for endoscopic submucosal dissection is 48.5-60 min. \[77, 89\], and, according to European scientists, the time for performing such interventions ranges from 142 to 176 minutes \[7, 78, 144, 187\]. According to Japanese clinical guidelines, the preferred method for removing large epithelial neoplasms of the colon with suspected intramucosal invasion is ESD, and European and American guidelines talk about the possible use of EMR, including in parts. In addition, unlike Japanese guidelines, where it is considered unsafe to remove a neoplasm in parts in assessing its radicality, Western guidelines allow the use of EMR in parts. Thus, endoscopic resection of the mucous membrane and endoscopic dissection in the submucosal layer are currently successfully used in the treatment of epithelial formations, but the advantages and disadvantages of each technique for a particular type of neoplasm, its histological nature and localization require systematization and clarification. The place of endoscopic mucosal resection and submucosal dissection in the removal of epithelial lesions of the colon has not been definitively established. Technical aspects, risk factors for complications, and long-term results of these types of endoscopic interventions require additional analysis.

Endoscopic interventions on the colon are accompanied by a certain percentage of complications. The most common complications of endoscopic removal of colon neoplasms are bleeding and perforation, the frequency of which varies from 0.08% to 10% depending on the analyzed method and patient sample \[93, 120\]. Given the wide variability of the avai

Где проходит

0 центров

Центры в реестре не указаны.

Откуда эта информация

  • ClinicalTrials.gov (U.S. National Library of Medicine) · NCT07041229 Официальный реестр (США) · загружено 9 ноября 2026
    Номер протокола, название, цель, статус, набор участников, сроки, число участников, спонсор

Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.